Published in Am J Gastroenterol on May 01, 1998
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg (2000) 1.63
Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism. Eur J Clin Pharmacol (2008) 1.45
Barrett's esophagus and the increasing role of endoluminal therapy. Therap Adv Gastroenterol (2008) 1.11
Globus pharyngeus: a review of its etiology, diagnosis and treatment. World J Gastroenterol (2012) 1.10
Acid peptic diseases: pharmacological approach to treatment. Expert Rev Clin Pharmacol (2009) 1.00
Gastroesophageal reflux disease in asthma: effects of medical and surgical antireflux therapy on asthma control. Ann Surg (2000) 0.95
Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in Japanese. Eur J Clin Pharmacol (2014) 0.90
Refractory chronic cough due to gastroesophageal reflux: Definition, mechanism and management. World J Methodol (2015) 0.89
Nocturnal acid breakthrough - approach to management. MedGenMed (2004) 0.86
Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. World J Gastroenterol (2003) 0.81
Barrett's oesophagus: the new endoscopic modalities have a future. Gut (2005) 0.80
Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study. Eur J Gastroenterol Hepatol (2015) 0.79
Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2017) 0.78
Dose-response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes. Eur J Clin Pharmacol (2011) 0.78
Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria. Mol Pharm (2013) 0.78
Comparing the acid-suppressive effects of three brands of generic lansoprazole with the original: pharmacokinetic bioequivalence tests do not necessarily guarantee pharmacodynamic equivalence. Dig Dis Sci (2008) 0.78
New method for long-term monitoring of intragastric pH. World J Gastroenterol (2007) 0.78
Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors? Dig Dis Sci (2000) 0.77
The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. Gastroenterol Res Pract (2014) 0.76
Pharmacologic Management of Gastroesophageal Reflux Disease. Curr Treat Options Gastroenterol (2002) 0.76
Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect? Dig Dis Sci (2007) 0.75
A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough. J Thorac Dis (2016) 0.75
Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors? J Neurogastroenterol Motil (2017) 0.75
Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole. BMC Gastroenterol (2014) 0.75
Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. BMC Gastroenterol (2008) 0.75
Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy. J Clin Biochem Nutr (2017) 0.75
Nocturnal acid breakthrough in subjects taking PPI b.i.d. Am J Gastroenterol (1999) 0.75
Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy. Eur Arch Otorhinolaryngol (2006) 0.75
Secretagogue-dependent and -independent transport of zinc hydration forms in rat parietal cells. Pflugers Arch (2016) 0.75
Circadian variation of gastroesophageal reflux in children. Dig Dis Sci (2003) 0.75
Classification of oesophageal motility abnormalities. Gut (2001) 4.86
Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis (1976) 3.71
The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol (1988) 3.53
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology (2001) 3.35
Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci (1987) 3.07
Hormonal control of gastroesophageal-sphincter strength. N Engl J Med (1970) 2.74
Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med (1982) 2.63
The accuracy of the physical examination in the diagnosis of suspected ascites. JAMA (1982) 2.35
Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21
Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther (2011) 2.13
Evidence of gender differences in esophageal pain threshold. Am J Gastroenterol (1995) 2.09
Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther (2003) 2.05
Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med (1971) 2.03
Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med (1987) 2.02
Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci (1997) 1.99
Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol (1994) 1.97
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci (1988) 1.91
Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology (1986) 1.87
Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med (1989) 1.84
Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions. Dig Dis Sci (1991) 1.81
Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology (1972) 1.78
Congenital esophageal stenosis in adults. Am J Gastroenterol (2000) 1.77
Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med (1991) 1.77
Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci (1989) 1.72
Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol (1996) 1.72
Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg (2006) 1.66
Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1999) 1.65
Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther (1998) 1.65
Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol (1999) 1.63
Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology (1993) 1.60
Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol (1996) 1.58
Diffuse esophageal spasm: a reappraisal. Ann Intern Med (1984) 1.57
Achalasia and diffuse esophageal spasm. Arch Intern Med (1976) 1.52
High amplitude, peristaltic esophageal contractions associated with chest pain and/or dysphagia. Gastroenterology (1979) 1.51
Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med (1990) 1.49
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther (2001) 1.43
Effects of octreotide on esophageal visceral perception and cerebral evoked potentials induced by balloon distension. Am J Gastroenterol (1999) 1.43
Effect of dry swallows and wet swallows of different volumes on esophageal peristalsis. J Appl Physiol (1975) 1.42
Pneumatic balloon dilation in achalasia: a prospective comparison of balloon distention time. Am J Gastroenterol (1998) 1.39
Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. Arch Intern Med (1995) 1.39
Prospective manometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction. Gastroenterology (1983) 1.39
Experimental esophagitis in cats impairs lower esophageal sphincter pressure. Gastroenterology (1975) 1.38
Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol (1996) 1.34
Caffeine and the lower esophageal sphincter. Am J Dig Dis (1972) 1.33
Altered gastric emptying and secretion in primary anorexia nervosa. Gastroenterology (1979) 1.33
Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc (2001) 1.33
Prospective randomized comparison of pneumatic dilatation technique in patients with idiopathic achalasia. Dig Dis Sci (1999) 1.32
Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol (1993) 1.31
A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol (1989) 1.28
Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology (1986) 1.25
Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci (1998) 1.23
Respiratory complications of gastroesophageal reflux. Arch Intern Med (1985) 1.23
Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. Am J Physiol (1997) 1.22
The spleen percussion sign. A useful diagnostic technique. Ann Intern Med (1967) 1.22
Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol (2001) 1.21
Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR Am J Roentgenol (1987) 1.20
Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin. N Engl J Med (1974) 1.20
Lower esophageal sphincter response to gastric alkalinization. A new mechanism for treatment of heartburn with antacids. Ann Intern Med (1971) 1.19
Imipramine decreases oesophageal pain perception in human male volunteers. Gut (1998) 1.19
Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application. J Clin Gastroenterol (1986) 1.18
Eastimation of liver size by percussion in normal individuals. Ann Intern Med (1969) 1.17
Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther (2006) 1.17
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology (1998) 1.17
Vigorous achalasia: original description requires minor change. J Clin Gastroenterol (2001) 1.16
Effect of head position on the dynamics of the upper esophageal sphincter and pharynx. Dysphagia (1993) 1.16
Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci (1998) 1.15
Fundoplication eliminates chronic cough due to non-acid reflux identified by impedance pH monitoring. Thorax (2005) 1.15
Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol (1996) 1.15
Pharyngeal and upper esophageal sphincter manometry in the evaluation of dysphagia. J Clin Gastroenterol (2001) 1.14
Muscle anatomy of the human esophagus. J Clin Gastroenterol (1986) 1.14
Modern solid state computerized manometry of the pharyngoesophageal segment. Dysphagia (1993) 1.13
Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology (1987) 1.13
Relationship of radionuclide liquid bolus transport and esophageal manometry. J Lab Clin Med (1987) 1.13
Inhibition of the lower oesophageal sphincter by fat--a mechanism for fatty food intolerance. Gut (1973) 1.11
Evaluation of dysphagia: a careful history is crucial. Dysphagia (1987) 1.11
Angiosarcoma of the small intestine: a case report and literature review. Am J Gastroenterol (1994) 1.11
Pulmonary aspiration as a consequence of gastroesophageal reflux: a diagnostic approach. Dig Dis Sci (1979) 1.11
Abnormal esophageal pressures in reflux esophagitis: cause or effect? Am J Gastroenterol (1986) 1.11
Differential sensitivity of the human esophagus to pentagastrin. Am J Physiol (1972) 1.10
Effects of position on oesophageal function: studies using combined manometry and multichannel intraluminal impedance. Neurogastroenterol Motil (2003) 1.10
Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther (2011) 1.10
Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci (1997) 1.10
Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol (1995) 1.10
Esophageal mythology. JAMA (1978) 1.09
Clearance mechanisms of the aperistaltic oesophagus: the "pump gun" hypothesis. Gut (2005) 1.08
The acid suppression test for unexplained chest pain. Gastroenterology (1998) 1.07